Millennium-Management

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
4,153
Total Value
89294203494
Accession Number
0001273087-25-000019
Form Type
13F-HR
Manager Name
Millennium-Management
Data Enrichment
85% identified
3,515 identified638 unidentified

Holdings

4,153 positions • $89.3B total value
Manager:
Search and click to pin securities to the top
Page 113 of 208
Idaho Strategic Resources, Inc.
Shares:188.5K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
HARTFORD INSURANCE GROUP, INC.
Shares:21.8K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
OIL STATES INTERNATIONAL, INC
Shares:523.7K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
HALOZYME THERAPEUTICS, INC.
Shares:42.2K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
90187BAB7
Shares:—
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
Mobileye Global Inc.
Shares:186.4K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
TaskUs, Inc.
Shares:196.7K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
LATAM AIRLINES GROUP S.A.
Shares:85.2K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
DANA Inc
Shares:200.0K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
46138G508
Shares:128.8K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
Jazz Pharmaceuticals plc
Shares:21.4K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
Westrock Coffee Co
Shares:368.6K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
464286103
Shares:113.5K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
RECURSION PHARMACEUTICALS, INC.
Shares:502.1K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
Zurn Elkay Water Solutions Corp
Shares:80.4K
Value:$2.7M
% of Portfolio:0.0% ($2.7M/$89.3B)
Bioventus Inc.
Shares:289.2K
Value:$2.6M
% of Portfolio:0.0% ($2.6M/$89.3B)
Gambling.com Group Ltd
Shares:208.7K
Value:$2.6M
% of Portfolio:0.0% ($2.6M/$89.3B)
CENTENE CORP
Shares:43.3K
Value:$2.6M
% of Portfolio:0.0% ($2.6M/$89.3B)
WINMARK CORP
Shares:8.3K
Value:$2.6M
% of Portfolio:0.0% ($2.6M/$89.3B)
MidWestOne Financial Group, Inc.
Shares:88.6K
Value:$2.6M
% of Portfolio:0.0% ($2.6M/$89.3B)